Bristol-Myers Squibb
BMY
#187
Rank
A$172.82 B
Marketcap
A$84.61
Share price
-0.77%
Change (1 day)
22.60%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2026 (TTM): A$6.66

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is A$6.50. In 2025 the company made an earnings per share (EPS) of A$4.95 an increase over its 2024 EPS that were of A-$6.33.

EPS history for Bristol-Myers Squibb from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$6.6634.53%
2025A$4.95-178.28%
2024A-$6.33-213.92%
2023A$5.5530.2%
2022A$4.26-6.04%
2021A$4.54-179.29%
2020A-$5.72-281.37%
2019A$3.16-27.21%
2018A$4.34
2016A$3.82175.26%
2015A$1.39-19.83%
2014A$1.73-22.44%
2013A$2.2334.48%
2012A$1.66

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$12.50 92.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$9.53 46.70%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.09-83.26%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$5.11-21.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$42.77 558.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$23.21 257.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$2.72-58.09%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
A$8.13 25.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$1.81-72.12%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$9.56 47.14%๐Ÿ‡ฌ๐Ÿ‡ง UK